By: Kristin Brooks Managing Editor, Contract Pharma Merck and Hansoh Pharma, a Chinese biopharmaceutical company, have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist
Where it works: Adipose tissue (fat cells): Reduces inflammation and may improve fat metabolism Pancreas: Works alongside GLP-1 to enhance insulin secretion Brain: May contribute to appetite regulation (research ongoing) Weight loss contribution: When GIP is added to GLP-1 (as in tirzepatide), weight loss increases from ~15% to ~22%
This formula pairs Glutathione, the master antioxidant, with Acetyl Cysteine, a precursor that boosts glutathione production inside the skin
Step forward, copper peptides
Assessment of annual cost of substance use disorder in US hospitals
Shellfish, soybeans, wheat germ oil, sunflower seeds, flaxseed, fish, and root beer could also make bruising worse